Wenshi Wang

3.6k citations
74 papers · 2.4k indexed · 1 hit paper · h-index 25

Wenshi Wang

73 papers receiving 2.4k citations

Hit Papers

Safety, Efficacy, and Biomarkers of Nivolumab With Vaccin...4402013202620172021100200300400

Peers

Wenshi Wang
Comparison fields: 5 of 129
  • Hepatology 662
  • Immunology 843
  • Oncology 833
  • Infectious Diseases 497
  • Epidemiology 594
Replace Brian J. Thomson with:
Brian J. Thomson United Kingdom
Linda Cook United States
Kazumoto Murata Japan
Keiji Ueda Japan
Mina Nakagawa Japan
Christoph Neumann‐Haefelin Germany
Shogo Tanaka Japan
Ranjit Ray United States
Luisa Imberti Italy
E A Wierenga Netherlands
Wenshi Wang relative to Brian J. Thomson United Kingdom Brian J. Thomson's profile →
Citations per field
00.5×
Brian J. Thomson · 1×
Citations per year

Countries citing papers authored by Wenshi Wang

Since Specialization
Citations

This map shows the geographic impact of Wenshi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenshi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenshi Wang more than expected).

Fields of papers citing papers by Wenshi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenshi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenshi Wang. The network helps show where Wenshi Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wenshi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wenshi Wang Line = papers co-authored together Wenshi Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20243
3 202318
4 20235
5 20232
6 20234
7 20234
8 202226
9 20212
10 201839
11 201827
12 201646
13 201650
14 20133
15 20136
16 20136
17 20126
18 20128
19 2009230
20
Studies on relationship between immune inhibition and apoptosis of T cells in mice infected with Schistosoma japonicum.
20002

About Wenshi Wang

Wenshi Wang is a scholar working on Hepatology, Infectious Diseases and Immunology, having authored 74 papers that have together received 2.4k indexed citations. Recurring topics across this work include Hepatitis Viruses Studies and Epidemiology (19 papers), Hepatitis C virus research (17 papers), Viral gastroenteritis research and epidemiology (14 papers), Viral Infections and Immunology Research (12 papers), Hepatitis B Virus Studies (11 papers), interferon and immune responses (8 papers), Viral Infections and Vectors (7 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Hepatology (662 citations), Immunology (843 citations) and Oncology (833 citations). Wenshi Wang has collaborated with scholars based in China, Netherlands and United States. Frequent co-authors include Qiuwei Pan, Maikel P. Peppelenbosch, Lei Xu, Jeffrey S. Weber, Yuebang Yin, Junhong Su, Daohai Yu, Bin Yu, Xiuhua Zhao and Amod A. Sarnaik. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026